The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy (Q34667753)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy |
scientific article |
Statements
1 reference
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy (English)
1 reference
Tait D Shanafelt
1 reference
Justin Boysen
1 reference
Neil E Kay
1 reference
Asish K Ghosh
1 reference
Charla Secreto
1 reference
Traci Sassoon
1 reference
Debabrata Mukhopadhyay
1 reference
6 December 2010
1 reference
Identifiers
1 reference